Health Minister Mandaviya Conducts Review Meeting; Says Sufficient Buffer Stock Of Covid-19 Drugs Available In IndiaUnion Health Minister Mansukh Mandaviya

The Union Ministry of Health and Family Welfare has assured that India has sufficient stock of the Covid-19 drugs after Union Minister Mansukh Mandaviya assessed the supply and availability of these medicines on Wednesday.

A strategic buffer stock has been created for about eight drugs, namely: Posaconazole, Enaxopirin, Dexamethasone, Remdesivir, Amphotericin B deoxycholate, Tocilizumab, Methyl Predinisolone and also intravenous Immunoglobulin.

The Health Ministry added that adequate stock of medicines and raw materials have been made available in necessary quantities across the country.

Meanwhile, Union Minister Mandaviya also conducted a review of the prevalent situation of the pandemic in Tamil Nadu, Kerala and Karnataka. He stressed upon taking the appropriate measures to restrict the inter-state spread of the virus.

Moreover, the state health ministers of Karnataka and Tamil Nadu were directed to ramp up the pace of vaccination in the districts that border Kerala, possibly owing to the rapid surge of cases in the southern state.

Senior officials from the Union Health Ministry were a part of this review meeting chaired by Mandaviya, Times of India reports.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement